About This Publication:

  • Print This Page
  • Text a Friend
  • Subscribe to an RSS Feed

Sample Content 

LOGIN


Sign up to stay informed--receive email notifications for this journal

Human Gene Therapy Package

Human Gene Therapy,
Human Gene Therapy Methods

Editor-in-Chief: James M. Wilson, MD, PhD
Methods Editor: Thierry VandenDriessche, PhD

ISSN: 1043-0342 • Published 18 issues annually • Online ISSN: 1557-7422

Latest Impact Factor* is 4.218

*2011 Journal Citation Reports® published by Thomson Reuters, 2012

Featured Press Releases and Editorial Content

  • Human Gene Therapy Journal Expands to Cover Clinical Development in Early 2013...Read Now
  • Method to Prevent Rejection of Disease-Fighting Proteins...Read Now
  • Editor-in-Chief Jim Wilson videocast on gene therapy as a disruptive science
    • Videocast with Dr. Wilson and John Sterling of Genetic Engineering & Biotechnology News...
      Watch Now
    • Commentary by Dr. Wilson...Read Now
    • View the entire podcast series!

Overview

Human Gene Therapy is the premier, multidisciplinary journal covering all aspects of gene therapy. The Journal publishes in-depth coverage of DNA, RNA, and cell therapies by delivering the latest breakthroughs in research and technologies. Human Gene Therapy provides a central forum for scientific and clinical information, including ethical, legal, regulatory, social, and commercial issues, which enables the advancement and progress of therapeutic procedures leading to improved patient outcomes, and ultimately, to curing diseases.

The HGT Package includes Human Gene Therapy, the flagship, is published 12 times per year, and HGT Methods, a bimonthly journal, focuses on the applications of gene therapy to product testing and development.

HGT Package coverage includes:

  • Improvements in vector developments
  • Delivery systems
  • Cell therapy
  • Small nucleic acid therapeutics, including RNAi
  • Clinical trials and animal models

Human Gene Therapy was voted one of the most influential journals in Biology and Medicine over the last 100 years by the Biomedical & Life Sciences Division of the Special Libraries Association.

Human Gene Therapy and HGT Methods, are under the editorial leadership of Editor-in-Chief James M. Wilson, MD, PhD, University of Pennsylvania School of Medicine, Gene Therapy Program, Department of Pathology and Laboratory Medicine; Deputy Editor George Dickson, Institute of Biomedical & Life Sciences, School of Biological Sciences, University of London; Methods Editor Thierry VandenDriessche, PhD, Free University of Brussels (VUB); and other leading investigators. View the entire editorial board.

Audience: Geneticists, medical geneticists, biological scientists, microbiologists, molecular biologists, virologists, experimental researchers, and experimental medicine specialists, among others.

Human Gene Therapy and HGT Methods provide “Instant Online” publication 72 hours after acceptance

This subscription includes:


Read Online

Editor-in-Chief: James M. Wilson, MD, PhD
ISSN: 1043-0342 • Monthly • Online ISSN: 1557-7422
Tables of Content   •   Read a Free Issue
Editorial Board   •   Author Information   •   Subscribe

Human Gene Therapy is the definitive peer-reviewed rapid-publication journal covering all aspects of human gene therapy.  The Journal publishes scientific papers on original investigations into the transfer and expression of genes in mammals, including humans with in-depth coverage of DNA, RNA, and cell therapies. Improvements in vector development, delivery systems, and animal models, particularly in the areas of cancer, heart disease, viral disease, genetic disease, and neurological disease, are covered. 



Read Online

Editor-in-Chief: James M. Wilson, MD, PhD
ISSN: 1946-6536  • Bimonthly  •  Online ISSN: 1946-6544
Editorial Board  •   Author Information  •  Subscribe

Human Gene Therapy Methods (HGT Methods) is an expansion of the flagship Human Gene Therapy, publishing technological advances in cell and gene therapy that promote the development of gene therapy products into successful therapeutics. The Journal breaks new ground as the first to exclusively focus on the applications of gene therapy to product testing and development.


[ Back to Top ]

The Official Journal of nine international societies:

DG-GT e.V.

 

Indexed/Abstracted in:

MEDLINE; Current Contents®/Life Sciences; Science Citation Index Expanded; Social Sciences Citation Index®; Biotechnology Citation Index®; BIOSIS Previews; Journal Citation Reports/Science Edition; Derwent Drug File; EMBASE/Excerpta Medica; EMBiology; Scopus; Chemical Abstracts; ProQuest
 

The views, opinions, findings, conclusions and recommendations set forth in any Journal article are solely those of the authors of those articles and do not necessarily reflect the views, policy or position of the Journal, its Publisher, its editorial staff or any affiliated Societies and should not be attributed to any of them.

Recommended Publications

You may be interested in the following publications:

    Tissue Engineering, Parts A, B, & C

    Tissue Engineering, Parts A, B, & C

    The preeminent, biomedical journal bringing together the principles of engineering and life sciences to advance the field with cutting-edge research and applications on all aspects of tissue growth and regeneration.

    Nucleic Acid Therapeutics

    Nucleic Acid Therapeutics

    formerly Oligonucleotides

    Focuses on cutting-edge research and applications to find and examine new approaches using nucleic acids in therapeutics including oligonucleotides, gene modification, aptamers, RNA nanoparticles, ribozymes, and more.

    Stem Cells and Development

    Stem Cells and Development

    Globally recognized as the trusted source for critical, even controversial coverage of emerging hypotheses and novel findings on stem cells of all tissue types and their potential therapeutic applications.

    Zebrafish

    Zebrafish

    Solely focused on disseminating the latest cutting-edge advances in the zebrafish as a model organism for the study of vertebrate development, with attention to other aquarium species including medaka, Fugu, and Xiphophorus.

Browse All Publications »